Invention Grant
- Patent Title: Farnesoid X receptor modulators
-
Application No.: US16124139Application Date: 2018-09-06
-
Publication No.: US10532061B2Publication Date: 2020-01-14
- Inventor: Roberto Pellicciari
- Applicant: Intercept Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee Address: US NY New York
- Agency: Intercept Pharmaceuticals, Inc.
- Agent Michelle Iwamoto-Fan
- Priority: EPPCT/EP2014/059896 20140514
- Main IPC: A61K31/575
- IPC: A61K31/575 ; C07J9/00 ; A61P1/16 ; A61P1/00 ; C07J41/00 ; C07J31/00 ; C07J71/00
Abstract:
The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein R1, R2, R3, R4, R5, and R6 are as described herein. The present invention relates generally to selective FXR agonists and to methods of making and using them.
Public/Granted literature
- US20190209586A1 FARNESOID X RECEPTOR MODULATORS Public/Granted day:2019-07-11
Information query
